Literature DB >> 12170314

Impaired production of plasma interleukin-6 in patients with Parkinson's disease.

M V Selikhova1, N E Kushlinskii, N V Lyubimova, E I Gusev.   

Abstract

The contents of interleukin-6 in the plasma from patients with Parkinson's disease and endogenous depression were compared by enzyme immunoassay. Interleukin-6 content in the plasma increased in the early stage of idiopathic parkinsonism complicated by depressive syndrome. A correlation was found between interleukin-6 content and changes in higher mental activity estimated by neuropsychological tests.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12170314     DOI： 10.1023/a:1015120930920

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN： 0007-4888            Impact factor:   0.804


  9 in total

1.  Interleukin-6 serum levels in patients with Parkinson's disease.

Authors:  Kerly Wollmeister Hofmann; Artur Francisco Schumacher Schuh; Jonas Saute; Raquel Townsend; Daniele Fricke; Renata Leke; Diogo O Souza; Luis Valmor Portela; Márcia Lorena Fagundes Chaves; Carlos R M Rieder
Journal:  Neurochem Res       Date:  2009-02-13       Impact factor: 3.996

Review 2.  Immune system responses in Parkinson's disease: Early and dynamic.

Authors:  Malú G Tansey; Marina Romero-Ramos
Journal:  Eur J Neurosci       Date:  2018-12-10       Impact factor: 3.386

Review 3.  Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?

Authors:  Marina Romero-Ramos; Marianne von Euler Chelpin; Vanesa Sanchez-Guajardo
Journal:  Hum Vaccin Immunother       Date:  2014-03-26       Impact factor: 3.452

Review 4.  Inflammatory markers and depression in Parkinson's disease: a systematic review.

Authors:  Luis Guilherme Ramanzini; Luís Fernando Muniz Camargo; Juliana Oliveira Freitas Silveira; Guilherme Vargas Bochi
Journal:  Neurol Sci       Date:  2022-08-30       Impact factor: 3.830

Review 5.  Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases.

Authors:  M Reale; N H Greig; M A Kamal
Journal:  Mini Rev Med Chem       Date:  2009-09       Impact factor: 3.862

6.  Qigong Exercise May Reduce Serum TNF-α Levels and Improve Sleep in People with Parkinson's Disease: A Pilot Study.

Authors:  Sanghee Moon; Marshall Schmidt; Irina V Smirnova; Yvonne Colgrove; Wen Liu
Journal:  Medicines (Basel)       Date:  2017-04-23

Review 7.  Cytokine-, Neurotrophin-, and Motor Rehabilitation-Induced Plasticity in Parkinson's Disease.

Authors:  Gabriella Policastro; Matteo Brunelli; Michele Tinazzi; Cristiano Chiamulera; Dwaine F Emerich; Giovanna Paolone
Journal:  Neural Plast       Date:  2020-11-26       Impact factor: 3.599

8.  The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease.

Authors:  Neus Rabaneda-Lombarte; Joan Serratosa; Jordi Bové; Miquel Vila; Josep Saura; Carme Solà
Journal:  J Neuroinflammation       Date:  2021-04-06       Impact factor: 8.322

Review 9.  Biomarker of Neuroinflammation in Parkinson's Disease.

Authors:  Tsai-Wei Liu; Chiung-Mei Chen; Kuo-Hsuan Chang
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.